Depsidones could have the potential as lead metabolites for neurodegenerative illnesses and diabetes through their inhibition of butyrylcholinesterase, tyrosinase, α-glucosidase, and acetylcholinesterase enzymes. Here, ACHE is linked to diabetes mellitus.